How much funding has PhenoVista BioSciences raised?

PhenoVista BioSciences has disclosed $3M raised across 1 round.

Where is PhenoVista BioSciences headquartered?

PhenoVista BioSciences is headquartered in San Diego, US.

PhenoVista BioSciences

San Diego, US · Founded 2022 · Delaware corporation

PhenoVista provides contract research services focused on phenotypic and high-content imaging studies, using quantitative fluorescence microscopy and cell-based disease models to support R&D and drug discovery decisions. It serves life science and biotech researchers.

Biotech Deep Tech Healthtech

Founders & leadership

Brian ConnNamed on SEC filing

James G. EvansCEO

Anthony EssexNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2022

▶$3MraisedJan 2023 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Brian ConnExecutive Officer
James G. EvansExecutive Officer, Director
Anthony EssexExecutive Officer, Director

Offering amount: $3M
Amount sold: $3M
Minimum investment: $3M
First sale: Dec 2022
Incorporated: Corporation, Delaware, 2022
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Emulatebio76 shared keywordsEmulate develops Organ-Chip technology, including 30+ organ models such as liver, brain, and other human tissue chips, used for human-based preclinical drug safety and toxicity testing. It serves pharmaceutical and biomedical researchers as a human-relevant alternative to animal testing, and works closely with the FDA including acceptance into the ISTAND pilot program.

Companies competing with PhenoVista BioSciences for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken

Agency	Phase	Year	Amount
National Institutes of Health (NIH)National Institutes of Health	Phase I	2021	$249.9K
National Institutes of Health (NIH)National Institutes of Health	Phase II	2020	$1.4M
National Institutes of Health (NIH)National Institutes of Health	Phase I	2017	$149.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does PhenoVista BioSciences do?: PhenoVista provides contract research services focused on phenotypic and high-content imaging studies, using quantitative fluorescence microscopy and cell-based disease models to support R&D and drug discovery decisions. It serves life science and biotech researchers.
How much funding has PhenoVista BioSciences raised?: PhenoVista BioSciences has disclosed $3M raised across 1 round.
Where is PhenoVista BioSciences headquartered?: PhenoVista BioSciences is headquartered in San Diego, US.